Serum Levels of Hepcidin in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

Senates, Ebubekir; Yilmaz, Yusuf; Colak, Yasar; Ozturk, Oguzhan; Altunoz, Mustafa Erhan; Kurt, Ramazan; Ozkara, Selvinaz; Aksaray, Sebahat; Tuncer, Ilyas; Ovunc, Ayse Oya Kurdas
August 2011
Metabolic Syndrome & Related Disorders;Aug2011, Vol. 9 Issue 4, p287
Academic Journal
Background: Research suggests the presence of mild-to-moderate iron overload in patients with nonalcoholic fatty liver disease (NAFLD). The role played by hepcidin, the master regulatory hormone of systemic iron metabolism, in the pathogenesis of NAFLD remains controversial. The aims of this study were to: (1) Evaluate serum hepcidin levels in patients with biopsy-proven NAFLD and age- and sex-matched controls and (2) identify the potential associations of hepcidin with the clinical and biochemical characteristics of the study participants. Methods: Serum levels of hepcidin were measured by enzyme-linked immunosorbent assay and compared in 88 patients with NAFLD (56 males and 32 females; mean age, 44±11 years) and 88 controls (51 males and 37 females; mean age, 43±12 years). Moreover, concentrations of hepcidin were assessed in relation to the general characteristics of the study participants and the results of liver biopsy. Results: Serum levels of hepcidin were significantly higher in patients with NAFLD (63.5±19.5 ng/mL, P<0.001) compared with controls (32.7±8.3 ng/mL). Multivariable regression analyses in patients with NAFLD showed that hepcidin levels were positively associated with total cholesterol (β=6.9, t=3.3, P<0.01) and triglycerides (β=1.4, t=2.4, P<0.05), but not with iron parameters, histological staging, and pathological characteristics of NAFLD. Conclusions: Although subject to future confirmation, our data suggest that hepcidin levels are elevated in NAFLD and could be associated with lipid parameters in this setting.


Related Articles

  • The relationship between pro-hepcidin and serum biochemical parameters in chronic hemodialysis patients: a study on 54 patients. Larki, Rozina Abbasi; Seifi, Sepideh; Pezeshki, Mahboob Lesan // Tehran University Medical Journal;Feb2011, Vol. 68 Issue 11, p681 

    Background: Prohepcidin, a liver-derived peptide with antimicrobial properties, is regulated by factors such as iron load and inflammation. Hepcidin is a central player in iron homeostasis. It downregulates the iron exporter ferroportin, thereby inhibiting iron absorption, release and recycling....

  • Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA. Peters, Hilde P.E.; Rumjon, Adam; Bansal, Sukhvinder S.; Laarakkers, Coby M.M.; van den Brand, Jan A.J.G.; Sarafidis, Pantelis; Musto, Rebecca; Malyszko, Jolanta; Swinkels, Dorine W.; Wetzels, Jack F.M.; Macdougall, Iain C. // Nephrology Dialysis Transplantation;Oct2012, Vol. 27 Issue 10, p3923 

    Background Measurement of serum hepcidin levels may provide a useful alternative to the current methods of determining iron status in chronic haemodialysis (HD) patients. However, the biological variability of this pivotal regulator of iron homeostasis is unclear, and the impact of inflammation,...

  • Iron Status and Systemic Inflammation, but Not Gut Inflammation, Strongly Predict Gender-Specific Concentrations of Serum Hepcidin in Infants in Rural Kenya. Jaeggi, Tanja; Moretti, Diego; Kvalsvig, Jane; Holding, Penny A.; Tjalsma, Harold; Kortman, Guus A. M.; Joosten, Irma; Mwangi, Alice; Zimmermann, Michael B. // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Hepcidin regulation by competing stimuli such as infection and iron deficiency has not been studied in infants and it’s yet unknown whether hepcidin regulatory pathways are fully functional in infants. In this cross-sectional study including 339 Kenyan infants aged 6.0±1.1 months...

  • Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related Cirrhosis. Lin, Dong; Ding, Jing; Liu, Jian-Ying; He, Yi-Feng; Dai, Zhi; Chen, Cai-Zhong; Cheng, Wei-Zhong; Zhou, Jian; Wang, Xin // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Purpose: Excessive brain iron accumulation contributes to cognitive impairments in hepatitis B virus (HBV)-related cirrhotic patients. The underlying mechanism remains unclear. Hepcidin, a liver-produced, 25-aminoacid peptide, is the major regulator of systemic iron metabolism. Abnormal hepcidin...

  • Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Francque, S.; Verrijken, A.; Mertens, I.; Hubens, G.; Van Marck, E.; Pelckmans, P.; Michielsen, P.; Van Gaal, L. // International Journal of Obesity;Feb2011, Vol. 35 Issue 2, p270 

    Introduction:We previously demonstrated in an animal model that steatosis, in the absence of fibrosis, induces a significant rise in portal pressure, indicating substantial changes in liver hemodynamics. As assessment of portal pressure is an invasive procedure, non-invasive parameters are...

  • Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease. Beaton, Melanie D.; Subrata Chakrabarti; Adams, Paul C. // Annals of Hepatology: Official Journal of the Mexican Associatio;2014, Vol. 13 Issue 3, p353 

    Background. In non-alcoholic fatty liver disease (NALFD), it has often been assumed that an elevation in serum ferritin is likely related to inflammation rather than iron overload. Material and methods. Patients referred with NAFLD were entered into a clinical study of phlebotomy therapy. A...

  • Known and potential roles of transferrin in iron biology. Bartnikas, Thomas // BioMetals;Aug2012, Vol. 25 Issue 4, p677 

    Transferrin is an abundant serum metal-binding protein best known for its role in iron delivery. The human disease congenital atransferrinemia and animal models of this disease highlight the essential role of transferrin in erythropoiesis and iron metabolism. Patients and mice deficient in...

  • Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. Hyogo, Hideyuki; Yamagishi, Sho-ichi; Maeda, Sayaka; Fukami, Kei; Ueda, Seiji; Okuda, Seiya; Nakahara, Takashi; Kimura, Yuki; Ishitobi, Tomokazu; Chayama, Kazuaki // Clinical & Experimental Medicine;Feb2014, Vol. 14 Issue 1, p45 

    Although impaired synthesis and/or bioavailability of nitric oxide are considered to contribute to insulin resistance and the progression of liver disease in nonalcoholic fatty liver disease, role of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, has not been...

  • Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Petta, Salvatore; Miele, Luca; Bugianesi, Elisabetta; Cammà, Calogero; Rosso, Chiara; Boccia, Stefania; Cabibi, Daniela; Di Marco, Vito; Grimaudo, Stefania; Grieco, Antonio; Pipitone, Rosaria Maria; Marchesini, Giulio; Craxì, Antonio // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Background and Aims: Variant in glucokinase regulatory protein (GCKR), associated with lipid and glucose traits, has been suggested to affect fatty liver infiltration. We aimed to assess whether GCKR rs780094 C→T SNP influences the expression of steatosis, lobular inflammation and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics